Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Résumé
Hypertrophic cardiomyopathies (HCM) result from distinct single-point mutations in sarcomeric proteins that lead to muscle hypercontractility. While different models
Domaines
Biologie structurale [q-bio.BM]
Origine : Fichiers produits par l'(les) auteur(s)